Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Nanalysis Scientific Corp. V.NSCI

Alternate Symbol(s):  NSCIF

Nanalysis develops and manufactures compact MRI and NMR devices for clinical, laboratory, and industrial markets. These portable devices require no liquid helium or any other cryogens. The company’s devices are used in diagnostics and chemical analysis across a range of industries (medical, pharma, biotech, mining, oil and gas, and more) as well as numerous government and university research... see more

TSXV:NSCI - Post Discussion

Nanalysis Scientific Corp. > Strong growth 100%
View:
Post by GoldenArm on Oct 27, 2022 1:53pm

Strong growth 100%

Looks like the market for them is coming back strongly.  Get in now IMHO

Preliminary Q3 Revenue Expected to be at least $6.8 million

    The Company looks to report gross revenues for the third quarter ended September 30, 2022, of at least $6.8 million, representing an increase of over 100% year over year.  

Recent operational highlights during the third quarter of 2022 include:

    Benchtop NMR:  Both the 100MHz and 60MHz delivered strong results in terms of sales, shipped units, and average sales price.  This includes shipping a record number of 20 100MHz units in Q3 2022.

    MRI / Medical Imaging:  Nanalysis continues to be active in medical imaging and was awarded a contract win of C$1.1 million for a custom MRI system from customer based in France.

    K'Prime 3rd Party Equipment Sales: This business continues to be steady.

    Security Service/CATSA: We continue to execute successfully on the phase-in period of this contract and expect to "go live" in Alberta airports on November 1, 2022. We expect billings for this service in the fourth quarter of this year.

    High Field NMR/Quad Systems: The company continues to move towards a full high-field NMR product launch with Quad Systems. There have been delays in the completion of the full suite of modules, but revenue generation has begun related to specific component sales. We expect meaningful revenue to commence at Quad in the fourth quarter of 2022, with full product roll out and material revenue to start in 2023.
Be the first to comment on this post